Published in Harefuah on November 01, 1976
Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol (1998) 3.79
Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. J Clin Oncol (1998) 2.05
Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma. Cancer (2000) 1.51
Clinical diagnosis of secondary tumors of the heart and pericardium. Dis Chest (1969) 1.00
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur J Cancer Clin Oncol (1989) 0.98
5-Fluorouracil, doxorubicin (adriamycin) and mitomycin-C (FAM) in advanced gastric cancer: observations on response, patient characteristics, myelosuppression and delivered dosage. Oncology (1989) 0.92
Therapeutic irradiation of the chest and electrocardiographic changes. Clin Radiol (1969) 0.91
A new human ovarian carcinoma cell line: establishment and analysis of tumor-associated markers. Oncology (1985) 0.90
[Solitary metastatic involvement of the spleen in squamous cell carcinoma of the cervix]. Harefuah (1977) 0.89
The management of pericardial effusion in cancer patients. Chest (1977) 0.88
The effect of tamoxifen on the endometrium. Breast Cancer Res Treat (1993) 0.88
The mechanism of human bladder tumor implantation in an in vitro model. J Urol (1986) 0.87
High-density lipoprotein and extracellular matrix promotes growth and plating efficiency of normal human mammary epithelial cells in serum-free medium. Int J Cancer (1983) 0.87
Fetal hemoglobin screening in whole blood and in plasma of cancer patients. Tumour Biol (1991) 0.86
Isolated pericardial metastasis of parotid tumor origin. Head Neck Surg (1982) 0.85
Effect of beta-blocking drug propranolol on 131 I utilization in euthyroid patients. J Clin Pharmacol New Drugs (1972) 0.84
Spontaneous pneumothorax complicating lung metastases from carcinoma of the breast. Radiol Clin (Basel) (1977) 0.83
Metastatic bone involvement in gynecological malignancies. Radiol Clin (Basel) (1978) 0.83
Evaluation of fetal hemoglobin in various malignancies with reference to the patients' age. Tumour Biol (1988) 0.81
Thyroid carcinoma induced by irradiation for Hodgkin's disease. Report of a case. Acta Radiol Oncol Radiat Phys Biol (1978) 0.81
Breast cancer arising in surgical scars. J Surg Oncol (1976) 0.81
Parameters affecting the in vitro maturation of human monocytes to macrophages. Int J Cell Cloning (1986) 0.81
Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20). Eur J Immunol (1986) 0.81
Influence of propranolol on serum thyroxine in the rat. J Endocrinol (1972) 0.80
Familial nephritis. Isr J Med Sci (1967) 0.80
The carcinomatous neuropathy. A clinical and electro-physiological comparative study, with special reference to the effect of treatment on the nervous system. Eur Neurol (1970) 0.80
Involvement of heparanase in tumor metastasis and angiogenesis. Isr J Med Sci (1989) 0.80
Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian carcinoma. J Clin Oncol (1988) 0.79
Letter: Breast cancer arising in thoracotomy scars. Lancet (1976) 0.79
Synthesis and receptor-binding affinity of fluorotamoxifen, a possible estrogen-receptor imaging agent. J Med Chem (1985) 0.79
Adjuvant chemotherapy with and without radiotherapy in stage II breast cancer. Biomed Pharmacother (1988) 0.78
Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer. Biomed Pharmacother (1988) 0.78
Cyclophosphamide, adriamycin, DTIC and vincristine with methotrexate in the treatment of advanced soft tissue sarcomas. Isr J Med Sci (1989) 0.78
Platelet-tumor cell interaction with the subendothelial extracellular matrix: relationship to cancer metastasis. Radiother Oncol (1985) 0.78
Corticosteroids in radiation-induced pericarditis. Chest (1978) 0.78
Radiation therapy for locally advanced breast cancer: prognostic factors and complication rate. Eur J Surg Oncol (1990) 0.78
Detection of different interleukin-1 activities in human monocytes and monocytic cell lines. J Biol Response Mod (1986) 0.78
Growth of human mammary carcinoma cells from biopsy specimens in serum-free medium on extracellular matrix. Int J Cancer (1986) 0.78
Current concepts in cancer: ovary--treatment for stages III and IV. The multimodal approach to the treatment of stage III ovarian carcinoma. Int J Radiat Oncol Biol Phys (1982) 0.78
Prevention of human bladder tumor cell implantation in an in vitro assay. J Urol (1987) 0.78
Characterization of prolactin receptors and their distribution among American and Israeli women with breast cancer: implications for prediction of hormonal dependency and treatment. Biomed Pharmacother (1988) 0.77
Enzymes of gluconeogenesis in tumor-bearing rats. Isr J Med Sci (1970) 0.77
Combined modality treatment for stage III ovarian carcinoma. Radiother Oncol (1985) 0.77
The effect of estradiol on human myelomonocytic cells. II. Mechanism of enhancing activity of colony formation. J Reprod Immunol (1986) 0.77
The effect of estradiol on human myelomonocytic cells. 1. Enhancement of colony formation. J Reprod Immunol (1985) 0.77
The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinoma. Int J Radiat Oncol Biol Phys (1983) 0.77
Pleural effusion in breast cancer: influence upon clinical course and survival. Chemioterapia (1986) 0.76
In vitro differentiation and establishment of cell lines derived from human myelomonocytic leukemia cells. Immunol Lett (1986) 0.76
High-dose metoclopramide and dexamethasone as an antiemetic in outpatients receiving chemotherapy for breast cancer. Second study. Oncology (1987) 0.75
Alveolar rhabdomyosarcoma presenting as subacute intravascular coagulation. J Clin Pathol (1977) 0.75
[The modern management of malignant germ cell tumor of the ovary]. Harefuah (1987) 0.75
Adverse reaction to 99Tcm sulfur colloid in a routine examination. A case report. Radiol Clin (Basel) (1977) 0.75
Cisplatin, bleomycin, and methotrexate (PBM) chemotherapy in locally advanced and metastatic head and neck cancer. J Surg Oncol (1989) 0.75
Hepatic intraarterial antibiotic therapy for resistant hepatic abscesses. Int Surg (1990) 0.75
Aminoglutethimide as second line endocrine therapy in advanced breast cancer. Anticancer Res (1987) 0.75
Treatment of primary and metastatic liver cancer using an implantable chemoinfusion pump. Isr J Med Sci (1989) 0.75
Cyclic combination chemotherapy for metastatic breast cancer. Isr J Med Sci (1977) 0.75
[Bleomycin therapy]. Harefuah (1974) 0.75
First, second and third line chemotherapy programs in metastatic breast carcinoma. Isr J Med Sci (1982) 0.75
Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors. Oncology (1984) 0.75
Treatment of locally advanced breast carcinoma with high-dose external beam supervoltage radiotherapy. Isr J Med Sci (1982) 0.75
Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen. Eur J Surg Oncol (1985) 0.75
Acute fatal hypercalcemia complicating therapeutic surgical oophorectomy in breast cancer. Int Surg (1977) 0.75
Adriamycin, vinblastine and mitomycin C as second-line chemotherapy in advanced breast cancer. Cancer Chemother Pharmacol (1986) 0.75
Chemotherapy induction, consolidation radiotherapy and maintenance alternating chemotherapy in small cell carcinoma of the lung. Isr J Med Sci (1989) 0.75
Response to chemotherapy of breast carcinoma bone metastases: assessment by bone scan. Diagn Imaging (1979) 0.75
[Treatment of metastatic breast cancer with aminoglutethimide after failure of tamoxifen]. Harefuah (1984) 0.75
[Adriamycin in the treatment of primary carcinoma of the liver]. Harefuah (1976) 0.75
Second line hormonal therapy with aminoglutethimide in metastatic breast cancer. Acta Oncol (1990) 0.75
[Combined chemotherapy in metastatic breast cancer: predictive value of dose levels and performance status]. Harefuah (1986) 0.75
Immune complex-like materials in sera of patients with breast cancer: detection by complement-consumption assay. Isr J Med Sci (1982) 0.75
Duodenal ulcer complicating intraarterial chemotherapy. Gastrointest Endosc (1987) 0.75
Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas. Isr J Med Sci (1989) 0.75
Methylprednisolone and chlorpromazine in patients receiving cancer chemotherapy: a prospective non-randomized study. J Chemother (1989) 0.75
Methylprednisolone versus metoclopramide as antiemetic treatment in patients receiving adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) chemotherapy: a randomized crossover blind study. J Chemother (1989) 0.75
CA15-3 serum levels in breast cancer and other malignancies--correlation with clinical course. Isr J Med Sci (1989) 0.75
[Results with new cytotoxic agents]. Harefuah (1976) 0.75
Comparison of the response to PHA and suppressor macrophage function in different age groups of cancer patients and healthy controls. Cancer (1981) 0.75
Solitary lung involvement from clear cell carcinoma of the endometrium. Int Surg (1978) 0.75
Combined immunotherapy and chemotherapy with tuftsin plus cyclophosphamide in the treatment of non-small-cell carcinoma of the lung. Chemioterapia (1987) 0.75
Prognostic factors affecting treatment results with combination chemotherapy in metastatic breast cancer. Anticancer Res (1986) 0.75
Immunofluorescent characterization of fibronectin, laminin, and keratin in normal and neoplastic human mammary epithelial cells in culture and in breast tissue sections. Int J Tissue React (1986) 0.75
The effects of ionizing irradiation on production of thromboxane and prostacyclin by the isolated perfused rat kidney. In Vivo (1992) 0.75
[Life-threatening gastrointestinal toxicity during 5-fluorouracil therapy]. Harefuah (1977) 0.75
Levels of fibrinogen/fibrin degradation fragment E and related substances in sera and effusions of patients with malignant disease. J Cancer Res Clin Oncol (1983) 0.75
[Mammographic screening for breast cancer in Israel]. Harefuah (1988) 0.75
[The use of agonist analogues of luteinizing hormone--releasing hormone in the treatment of prostatic carcinoma]. Harefuah (1987) 0.75
Cyclic combination chemotherapy for metastatic breast cancer: comparison of two CMF schedules. Oncology (1981) 0.75
Vinblastine, cyclophosphamide and 5-fluorouracil (VEF) combination chemotherapy for metastatic hypernephroma. Oncology (1981) 0.75